![NA masthead new 1](https://prodcraftsa01.blob.core.windows.net/assets/products/neurology-alert/_contentImage/NA_masthead_new_1.png)
Neurology Alert – February 1, 2010
February 1, 2010
View Issues
-
Ocular Myasthenia in Seniors: A Case for Treatment
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia. -
Neuropathy in Liver Failure
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability. -
Treating Multiple Sclerosis: Why Wait?
Glatiramer acetate significantly delayed the onset of clinically definite multiple sclerosis (MS) in patients having a clinically isolated event and brain lesions consistent with MS. -
Dissecting the Subtypes of Parkinson's Disease
Dementia in Parkinson's disease is associated with a non-tremor-predominant phenotype, and the MAPT H1/H1 genotype. A rapidly progressing subtype without dementia has been identified, associated with another non-motor feature, depression. -
Pharmacokinetics of IV Immunoglobulins and Outcome in GBS
Fixed dose of IVIg may not be effective in all patients with GBS. -
What Is Frontotemporal Lobar Degeneration? New Clues Emerge
Two studies have identified a novel inclusion found in a subset of FTLD brains and categorize the clinical entity of the behavioral variant of FTLD, based on anatomical patterns. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions.